Insulet (PODD) Other Non Operating Income (2011 - 2026)
Insulet (PODD) posted Other Non Operating Income of $700000.0 for Q1 2026, down 77.42% on a QoQ basis from $3.1 million in Q4 2025, and up 101.77% year-over-year from $346926.0 in Q1 2025.
Insulet (PODD) Other Non Operating Income (2011 - 2026) Analysis & Trends
Insulet's Other Non Operating Income history runs 16 years deep, the most recent figure standing at $700000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 101.77% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.0 million (down 123.14% YoY) and the FY2025 annual result came in at $14.3 million, up 360.0% from the prior year.
- Other Non Operating Income was $700000.0 for Q1 2026 at Insulet, down from $3.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $12.1 million in Q3 2025 and bottomed at -$123.9 million in Q2 2025.
- A 5-year average of -$10.4 million and a median of -$200000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income plunged 585.71% — and 2025, when it surged 455.88%.
- Insulet's Other Non Operating Income stood at $1.5 million in 2022, then gained by 26.67% to $1.9 million in 2023, then slumped by 389.47% to -$5.5 million in 2024, then jumped by 156.36% to $3.1 million in 2025, then slumped by 77.42% to $700000.0 in 2026.
- Business Quant data shows PODD's Other Non Operating Income at $700000.0 in Q1 2026, $3.1 million in Q4 2025, and $12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Insulet | 11.08 Bn | 10.60 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 12.10 Mn |
| Jun 30, 2025 | -123.90 Mn |
| Mar 31, 2025 | -39.50 Mn |
| Dec 31, 2024 | -5.50 Mn |
| Sep 30, 2024 | -3.40 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -40.90 Mn |
| Sep 30, 2021 | -700,000.00 |
| Jun 30, 2021 | -40.10 Mn |
| Mar 31, 2021 | -2.60 Mn |
| Sep 30, 2020 | 1.00 Mn |